ABBYY FineReader 14 redefines the way offices work with

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
180
ABBYY FineReader 14 redefines the way offices work with documents

MILPITAS, CA--(Marketwired - Jan 24, 2017) - ABBYY ® , a leading provider of technologies and solutions to action information, today announced the availability of FineReader 14 , the next version of its flagship desktop software that combines award-winning optical character recognition (OCR) with advanced capabilities for working with PDFs and document comparison. With the new version, business professionals can easily manage and accomplish all kinds of daily tasks -- editing, converting, commenting and comparing documents -- using one, intuitive application. FineReader 14 comes with the main functionality required to work with any paper-based document and PDFs, whether scanned or digitally created.

"Paper continues to remain a key component of business workflows. An IDC survey 1 in the U.S. has confirmed that 65 percent of organizations are still heavily dependent on paper requiring greater efforts to transform information for further use," says Ivan Bodyagin, vice president of the FineReader Product Department at ABBYY. "By leveraging more than 20 years of experience in OCR development, ABBYY is bridging the gap between paper-based and digital information, providing a powerful tool to streamline document-driven processes."

ABBYY developed FineReader 14 in response to the needs of modern business professionals who require new capabilities for rapid document processing at the highest quality. Key areas of functionality and notable improvements include:

  • Highly accurate conversion of PDFs and scans into actionable formats: Ongoing improvements to ABBYY's OCR technology ensures that it continues to deliver exceptional results for converting scans and PDFs to editable and searchable formats such as Word, Excel ® , PowerPoint ® and PDF, while retaining all the original features that FineReader is renowned for, such as extended OCR capabilities and automated conversion.
  • PDF editing and collaboration: FineReader 14 is an all-in-one solution for working with PDFs and scans, with built-in advanced editing and collaboration tools for managing pages, content editing, reviewing, commenting, searching, filling forms, signing and protecting files.
  • Cross-format document comparison: An all-new "compare documents" feature detects and highlights any relevant textual changes between two versions of the same document, regardless of whether their format is PDF, Word, JPG, etc.
  • Deep OCR integration into PDF tools: FineReader 14 is the product of choice for those who work with scans and paper-based PDFs on a daily basis due to its ability to automatically apply OCR to PDFs when required.
  • Over 190 OCR languages: New version supports text recognition in more than 190 languages, including some difficult-to-digitize languages such as Korean, Chinese, Japanese and Arabic. It also comes with support for simple math formulas and English phonetic transcriptions.

Availability

ABBYY FineReader 14 is available immediately in three editions: Standard, Corporate and Enterprise, worldwide. It can be ordered through online stores and many retail outlets. For detailed product information and available versions, visit www.abbyy.com/finereader .

About ABBYY

ABBYY is a leading global provider of technologies and solutions that help businesses to action information. The company sets the standard in content capture and innovative language-based technologies that integrate across the information lifecycle. ABBYY solutions are relied on to optimize business processes, mitigate risk, accelerate decision making and drive revenue. ABBYY technologies are used and licensed by some of the largest international enterprises and government organizations, as well as SMBs and individuals. The company maintains offices in Australia, Canada, Cyprus, France, Germany, Japan, Russia, Spain, Taiwan, UAE, the UK, Ukraine, and the United States. For more information, visit www.ABBYY.com .

ABBYY and the ABBYY, ABBYY Logo, FineReader, ABBYY FineReader are either registered trademarks or trademarks of ABBYY Software Ltd. Other product names mentioned herein may be trademarks and/or registered trademarks of their respective owners and are hereby recognized.

1 IDC MaturityScape Benchmark: Digital Transformation of Document Workflows in the United States. International Data Corporation (IDC), September 2016

Media Contact : Karbo Communications for ABBYY Email Contact Margaret Pereira 925-989-8109

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI and Storytelling Make Waves in Science Education

Updated Category News Views 4

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 5

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 4

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 4

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 2

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 3

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading

Top 5 Most Recently Viewed Articles

Ten Four Truck Insurance Welcomes Chris Johnstone on Board

Updated Category News Views 76

Exciting Leadership Move at Ten Four Truck Insurance Ten Four Truck Insurance, recognized as a premier provider of insurance solutions tailored specifically for the trucking industry, has recently elevated Chris Johnstone to the position of Director of Partnerships. This strategic appointment is set to enhance the company's collaborative efforts and broaden its partner...

Continue Reading
Innovative Screed Hook Design Enhances Concrete Pouring Process

Updated Category News Views 165

Revolutionizing the Concrete Construction Process In the bustling world of construction, efficiency is key. An inventive mind has recently introduced a specialized screed hook that promises to streamline the concrete pouring process significantly. This innovation is designed with a focus on ease of use, making it a practical addition for contractors and workers alike....

Continue Reading
SCR Expands Offerings Through Global Partnerships in Business Formation

Updated Category News Views 201

SCR Expands Offerings Through Global Partnerships In recent developments, SCR has made significant strides in enhancing its Offshore Company Formation services by forging international partnerships. These collaborations provide businesses and individuals with increased flexibility in establishing structures that can facilitate asset protection, succession planning, and...

Continue Reading
Response Pharmaceuticals Achieves Milestone in RDX-002 Study

Updated Category News Views 171

Response Pharmaceuticals Makes Significant Progress in Clinical Trial Response Pharmaceuticals, Inc., a company specializing in innovative weight management solutions, has announced a pivotal moment in its clinical trajectory. The firm has completed early enrollment in a Phase 2 clinical trial assessing the efficacy of its investigational drug candidate, RDX-002. This...

Continue Reading
Fifth Third Bancorp Faces Decline in Profit Due to Higher Provisions

Updated Category News Views 81

Fifth Third Bancorp Reports Lower Profits Amid Rising Provisions Fifth Third Bancorp (NASDAQ: FITB), a prominent financial institution, has reported a decrease in its profits for the third quarter, primarily influenced by heightened provisions for loan losses. The bank's recent financial disclosures have caught the attention of investors, culminating in a nearly 3% drop...

Continue Reading